Ngenla (somatrogon)

pCPA File Number: 21798

Negotiation Status:

Concluded with an LOI

Indication(s):

Growth hormone deficiency

Sponsor/Manufacturer:

Pfizer Canada ULC

CDA-AMC Project Number:

SR0683-000

pCPA Engagement Letter Issued:

2022-08-17

Negotiation Process Concluded:

2022-11-28